Trending NewsTrending NewsNASDAQ:DOX Amdocs (DOX) Stock Price, News & Analysis $43.12 +1.66 (+4.00%) Closing price 04:00 PM EasternExtended Trading$43.56 +0.44 (+1.02%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Amdocs Stock (NASDAQ:DOX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Amdocs alerts:Sign Up Key Stats Today's Range$40.99▼$43.4150-Day Range$41.46▼$63.5752-Week Range$39.96▼$84.95Volume2.30 million shsAverage Volume1.32 million shsMarket Capitalization$4.65 billionP/E Ratio9.23Dividend Yield5.29%Price Target$78.33Consensus RatingHold Company Overview Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.AI Generated. May Contain Errors. Read More Amdocs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks94th Percentile Overall ScoreDOX MarketRank™: 4.68001570475 of 5 starsAmdocs scored higher than 94% of companies evaluated by MarketBeat, and ranked 85th out of 593 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingHold Consensus RatingAmdocs has received a consensus rating of Hold. The company's average rating score is 2.11, and is based on no strong buy ratings, 3 buy ratings, 4 hold ratings, and 2 sell ratings.Upside PotentialAmdocs has a consensus price target of $78.33, representing about 81.7% upside from its current price of $43.12.Amount of Analyst CoverageAmdocs has only been the subject of 4 research reports in the past 90 days.Read more about Amdocs' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth4.47% Earnings GrowthEarnings for Amdocs are expected to grow by 4.47% in the coming year, from $5.82 to $6.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Amdocs is 9.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.57.Price to Earnings Ratio vs. SectorThe P/E ratio of Amdocs is 9.23, which means that it is trading at a less expensive P/E ratio than the Technology sector average P/E ratio of about 44.74.Price to Earnings Growth RatioAmdocs has a PEG Ratio of 1.36. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAmdocs has a P/B Ratio of 1.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.97% of the float of Amdocs has been sold short.Short Interest Ratio / Days to CoverAmdocs has a short interest ratio ("days to cover") of 9.29.Change versus previous monthShort interest in Amdocs has recently decreased by 0.96%, indicating that investor sentiment is improving. Dividend5.0 / 5Dividend StrengthStrong Dividend LeadershipAmdocs is a leading dividend payer. It pays a dividend yield of 5.45%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthAmdocs has been increasing its dividend for 14 years.Dividend CoverageThe dividend payout ratio of Amdocs is 48.82%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Amdocs will have a dividend payout ratio of 37.50% next year. This indicates that Amdocs will be able to sustain or increase its dividend.Read more about Amdocs' dividend. News and Social Media3.2 / 5News Sentiment0.05 News SentimentAmdocs has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Technology companies.News Coverage This WeekMarketBeat has tracked 37 news articles for Amdocs this week, compared to 6 articles on an average week.Search Interest11 people have searched for DOX on MarketBeat in the last 30 days. This is an increase of 1,000% compared to the previous 30 days.MarketBeat Follows3 people have added Amdocs to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership1.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Amdocs insiders have not sold or bought any company stock.Percentage Held by Insiders15.40% of the stock of Amdocs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions92.02% of the stock of Amdocs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Amdocs' insider trading history. Receive DOX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amdocs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOX Stock News HeadlinesAmdocs Limited (DOX) Securities Investigation Notice - Levi & KorsinskyNovember 11 at 12:36 PM | prnewswire.comWall Street's Most Accurate Analysts Spotlight On 3 Tech Stocks Delivering High-Dividend YieldsNovember 11 at 7:50 AM | benzinga.comI'm handing you this stock todayElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.November 11 at 1:00 AM | Behind the Markets (Ad)DOX Securities Notice: Amdocs Limited Investors that Suffered Losses when Stock Plummeted 30% are Notified to Contact BFA Law about its Securities Fraud InvestigationNovember 11 at 6:03 AM | globenewswire.comAmdocs Announces First Quarter Fiscal 2027 Investor Conference ScheduleNovember 10 at 12:17 AM | finance.yahoo.comAmdocs: 30% Collapse Creates A Speculative Value OpportunityNovember 10 at 10:50 PM | seekingalpha.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amdocs Limited - DOXNovember 10 at 4:35 PM | globenewswire.comDOX Investor Notification: Amdocs Limited Investigated for Securities Fraud on behalf of Investors with Losses after T-Mobile Agreement Issues Lead to 30% Stock DropNovember 10 at 6:17 AM | prnewswire.comSee More Headlines DOX Stock Analysis - Frequently Asked Questions How have DOX shares performed this year? Amdocs' stock was trading at $80.51 on January 1st, 2026. Since then, DOX stock has decreased by 46.4% and is now trading at $43.12. How were Amdocs' earnings last quarter? Amdocs Limited (NASDAQ:DOX) released its quarterly earnings results on Tuesday, November, 3rd. The technology company reported $1.98 EPS for the quarter, meeting the consensus estimate of $1.98. The firm's quarterly revenue was up 3.8% on a year-over-year basis. Read the conference call transcript. Does Amdocs have any subsidiaries? The following companies are subsidiaries of Amdocs: Sourced Group, Openet, Telecom Technology Services, Vubiquity, Brite:Bill, Pontis, Vindicia, and others. Who are Amdocs' major shareholders? Amdocs' top institutional investors include Pzena Investment Management LLC (13.39%), Beutel Goodman & Co Ltd. (4.00%), Russell Investments Group Ltd. (1.03%) and Robeco Institutional Asset Management B.V. (0.70%). How do I buy shares of Amdocs? Shares of DOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Amdocs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amdocs investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Qualcomm (QCOM), Intel (INTC), Micron Technology (MU) and Home Depot (HD). Company Calendar Record date for 10/30 Dividend9/30/2026Ex-Dividend for 10/30 Dividend9/30/2026Dividend Payable10/30/2026Last Earnings11/03/2026Today11/11/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 7 days, DOX's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry IT Services Sub-IndustryIT Consulting & Other Services Current SymbolNASDAQ:DOX CIK1062579 Webwww.amdocs.com Phone(314) 212-7000Fax1 314 212 7500Employees26,969Year Founded1982Price Target and Rating Average Price Target for Amdocs$78.33 High Price Target$97.00 Low Price Target$46.00 Potential Upside/Downside+81.7%Consensus RatingHold Rating Score (0-4)2.11 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$4.67 Trailing P/E Ratio9.23 Forward P/E Ratio7.09 P/E Growth1.36Net Income$497.42 million Net Margins10.59% Pretax Margin13.54% Return on Equity20.81% Return on Assets11.05% Debt Debt-to-Equity Ratio0.23 Current Ratio0.94 Quick Ratio0.94 Sales & Book Value Annual Sales$4.70 billion Price / Sales0.99 Cash Flow$8.76 per share Price / Cash Flow4.92 Book Value$30.88 per share Price / Book1.40Miscellaneous Outstanding Shares107,950,000Free Float91,326,000Market Cap$4.65 billion OptionableOptionable Beta0.42 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:DOX) was last updated on 11/11/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | Sponsored55+? Elon’s Gift…James Altucher points to Elon Musk's latest FCC filing as a potential turning point for retirees relying on So...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amdocs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Amdocs With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.